(Q42633225)

4 November 2017

Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders (English)

1 reference

4 November 2017

0 references

0 references

Roxanne Carr

1

1 reference

4 November 2017

Michael B Wasdell

2

1 reference

4 November 2017

Donald Hamilton

3

1 reference

4 November 2017

Margaret D Weiss

4

1 reference

4 November 2017

Roger D Freeman

5

1 reference

4 November 2017

Joseph Tai

6

1 reference

4 November 2017

Wop J Rietveld

7

1 reference

4 November 2017

James E Jan

8

1 reference

4 November 2017

1 November 2007

1 reference

Journal of Pineal Research

4 November 2017

1 reference

4 November 2017

43

1 reference

4 November 2017

4

1 reference

4 November 2017

351-359

1 reference

Pharmacologic management of insomnia in children and adolescents: consensus statement

4 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Melatonin supplementation for severe and intractable sleep disturbance in young people with genetically determined developmental disabilities: short review and commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Melatonin as a chronobiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Melatonin as a hypnotic: pro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Melatonin regulates circadian electroretinogram rhythms in a dose- and time-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Brain mechanisms that control sleep and waking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Effect of controlled-release melatonin on sleep quality, mood, and quality of life in subjects with seasonal or weather-associated changes in mood and behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Use of melatonin in the treatment of paediatric sleep disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Use of melatonin to treat sleep disorders in tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Brief report: melatonin facilitates sleep in individuals with mental retardation and insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Melatonin: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Melatonin: reducing the toxicity and increasing the efficacy of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Evidence supporting the use of melatonin in short gestation infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Clinical efficacy of agomelatine in depression: the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Medication Use in the Treatment of Pediatric Insomnia: Results of a Survey of Community-Based Pediatricians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

Incidences of new prescribing by British child and adolescent psychiatrists: a prospective study over 12 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2007.00485.X

10.1111/J.1600-079X.2007.00485.X

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference